No Data
No Data
J.P. Morgan Maintains Haemonetics(HAE.US) With Buy Rating
J.P. Morgan Remains a Buy on Haemonetics (HAE)
Haemonetics Corp.: Chan Will Receive an Annual Base Salary of $550,000 >HAE
Haemonetics Announces Executive Leadership Updates; Frank Chan Joins Haemonetics As Executive Vice President, Chief Operating Officer, Effective April 7, 2025
Express News | Haemonetics Announces Executive Leadership Updates
Press Release: Haemonetics Announces Executive Leadership Updates